Novo Integrated Sciences

NVOS58

Penny Stock

$0.14arrow_drop_down11.32%-$0.01

Penny Stock

NVOS58

$0.14

arrow_drop_down11.32%-$0.01

Penny Stock

Performance History

Key Stats
Open	$0.18
Prev. Close	$0.17
EPS	-1.33
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$722.16K
PE Ratio	-

	LOW	HIGH
Day Range	0.11	0.18
52 Week Range	0.11	3.45

Ratios

Revenue	-





EPS	-1.33

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Novo Integrated Sciences (NVOS)

Novo Integrated Sciences, Inc. (NVOS) is a company that specializes in integrated healthcare solutions. With a mission to provide cutting-edge technologies and innovative therapies, NVOS aims to improve the quality of life for patients and healthcare providers alike. The company is committed to delivering comprehensive, personalized care that addresses the unique needs of each individual. Through their advanced medical technologies and therapies, NVOS is revolutionizing the healthcare industry.

One of the key aspects of NVOS is their focus on integrated sciences. By combining various scientific disciplines, such as biology, chemistry, and physics, NVOS is able to provide a holistic approach to healthcare. This interdisciplinary approach allows for a more comprehensive understanding of the human body and its complex systems, leading to more effective treatments and improved patient outcomes.

Websitecall_made

Sector: Healthcare
Industry: Medical Care Facilities
CEO: Mr. Robert Mattacchione
Headquarters: Bellevue
Employees: 115
Exchange: NASDAQ

add Novo Integrated Sciences to watchlist

Keep an eye on Novo Integrated Sciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Novo Integrated Sciences's (NVOS) price per share?

The current price per share for Novo Integrated Sciences (NVOS) is $0.15. The stock has seen a price change of -$0.02 recently, indicating a -11.33% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Novo Integrated Sciences (NVOS)?

For Novo Integrated Sciences (NVOS), the 52-week high is $3.45, which is 2.22K% from the current price. The 52-week low is $0.11, the current price is 35.45% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Novo Integrated Sciences (NVOS) a growth stock?

Novo Integrated Sciences (NVOS) has shown an average price growth of -7.34% over the past three years. It has received a score of 95 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Novo Integrated Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Novo Integrated Sciences (NVOS) stock price performance year to date (YTD)?

As of the latest data, Novo Integrated Sciences (NVOS) has a year-to-date price change of -80.66%. Over the past month, the stock has experienced a price change of -32.43%. Over the last three months, the change has been -63.89%. Over the past six months, the figure is -65.9%.

help

Is Novo Integrated Sciences (NVOS) a profitable company?

Novo Integrated Sciences (NVOS) has a net income of -$13.27M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 39.39% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -79.96% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 7.11%, providing insight into the company's sales performance and growth. The gross profit is $4.95M. Operating income is noted at -$8.55M. Furthermore, the EBITDA is -$8.19M.

help

What is the market capitalization of Novo Integrated Sciences (NVOS)?

Novo Integrated Sciences (NVOS) has a market capitalization of $722.16K. The average daily trading volume is 0.15, indicating the stock's liquidity and investor engagement.